Skip to main content
. 2021 Jul 30;13(1):1946918. doi: 10.1080/19420862.2021.1946918

Figure 3.

Figure 3.

N49P7 and VRC07-523LS variants with improved potency and some HEp-2 reactivity. (a) Matrix of VRC01-class antibody variants. (b) Neutralization IC50 values of N49P7 variants and VRC07-523LS variants against a 12-virus panel. (c) HEp-2 cell staining assay against N49P7 and VRC07 variants was performed in the concentration of 25 μg/ml along with control antibodies, VRC01LS, 4E10, VRC07-523LS, and VRC07-G54W. Control antibodies were assigned a score between 0 and 3. Test antibodies scored greater than 1 at 25 µg/ml were considered polyreactive